Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice.

Chrysoula G GialouriGerasimos EvangelatosMaria PappaAnastasios KaramanakosAlexios IliopoulosMaria G G TektonidouPetros P SfikakisGeorge E Fragoulis

Published in: Therapeutic advances in musculoskeletal disease (2022)

Normal CRP in PsA should not be used as surrogate marker of remission or low/MDA, therefore needs to be interpreted with caution in clinical decision-making.

Keyphrases

clinical practice
decision making
prostate cancer
breast cancer cells
ulcerative colitis
rheumatoid arthritis
cell death
cell cycle arrest
cell proliferation